FDA Allows Imports of China-Made Chemotherapy to Ease U.S. Shortage



In temporary move, Chinese drugmaker will be able to ship its cisplatin chemotherapy even though it hasn’t been FDA approved



In temporary move, Chinese drugmaker will be able to ship its cisplatin chemotherapy even though it hasn’t been FDA approved

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@technoblender.com. The content will be deleted within 24 hours.
business newsC&E Industry News FiltercancerCancer DrugschemotherapyChemotherapy/Radiotherapy/ImmunotherapyChinamadeContent TypescorporateCorporate/Industrial NewsEaseEconomyFactiva FiltersFDAgeneral newsgovernment policyHealthhealthcareHealthcare/Life Sciencesimmunotherapyimportsindustrial newslife sciencesMarketMedical Conditionsmedical treatmentsMedical Treatments/ProceduresMedicationsnew productsNew Products/ServicesOutputOutput/ProductionPharmaceuticalspoliticalPolitical/General NewsproceduresProductProduct ShortageProduct/Service ApprovalsProductionProductsProducts/ServicesRadiotherapyregulationRegulation/Government Policyservice approvalsServicesShortagespecialized drugsSpecialized Drugs/MedicationsSYNDu.s.WSJ-PRO-WSJ.comwsjhealth
Comments (0)
Add Comment